Zepbound Archives - Inside Precision Medicine

Inside Precision Medicine Amgen’s Weight Loss Candidate Shines in Phase I Study

Nutritionist calculating body mass index of a woman for obesity treatment in a clinic room. Both are women with dark hair and light skin and are sitting opposite each other next to a computer on a table.

News & Features

Amgen’s Weight Loss Candidate Shines in Phase I Study

February 6, 2024

Related Content

Biological Age Linked to Early Colorectal Cancer Risk

Biological Age Linked to Early Colorectal Cancer Risk

Terns Pharmaceuticals' Allosteric Inhibitor Shows “Best-in-Class” Potential in Phase I CML Study

Terns Pharmaceuticals' Allosteric Inhibitor Shows “Best-in-Class” Potential in Phase I CML Study

Amgen’s Obesity Candidate, MariTide, Shows Promise in Phase II

Amgen’s Obesity Candidate, MariTide, Shows Promise in Phase II

Visceral Fat in Midlife Linked to Alzheimer’s Disease

Visceral Fat in Midlife Linked to Alzheimer’s Disease